Private Advisor Group LLC acquired a new stake in shares of Xylem Inc. (NYSE:XYL) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 5,533 shares of the company’s stock, valued at approximately $252,000.

A number of other hedge funds also recently bought and sold shares of the stock. Renaissance Technologies LLC bought a new stake in Xylem during the first quarter valued at approximately $35,673,000. Legal & General Group Plc boosted its position in Xylem by 1.8% in the first quarter. Legal & General Group Plc now owns 767,829 shares of the company’s stock valued at $31,403,000 after buying an additional 13,271 shares during the last quarter. Meeder Asset Management Inc. boosted its position in Xylem by 45.9% in the first quarter. Meeder Asset Management Inc. now owns 25,240 shares of the company’s stock valued at $1,032,000 after buying an additional 7,938 shares during the last quarter. Geode Capital Management LLC boosted its position in Xylem by 1.1% in the first quarter. Geode Capital Management LLC now owns 1,484,650 shares of the company’s stock valued at $60,604,000 after buying an additional 15,589 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. boosted its position in Xylem by 362.8% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,240,920 shares of the company’s stock valued at $50,754,000 after buying an additional 972,803 shares during the last quarter. 84.69% of the stock is owned by hedge funds and other institutional investors.

Shares of Xylem Inc. (NYSE:XYL) traded down 0.91% on Friday, hitting $52.14. The company’s stock had a trading volume of 192,999 shares. The stock’s 50 day moving average is $50.03 and its 200-day moving average is $45.09. The company has a market cap of $9.34 billion, a price-to-earnings ratio of 27.84 and a beta of 1.15. Xylem Inc. has a 52 week low of $31.67 and a 52 week high of $52.68.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. The company had revenue of $932 million for the quarter, compared to analysts’ expectations of $927.69 million. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 earnings per share. On average, equities research analysts anticipate that Xylem Inc. will post $2.04 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 21st. Stockholders of record on Wednesday, August 31st were issued a dividend of $0.1549 per share. The ex-dividend date of this dividend was Monday, August 29th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 1.18%. Xylem’s dividend payout ratio (DPR) is presently 33.16%.

Several equities analysts have issued reports on the company. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 target price on the stock in a research report on Monday, August 22nd. Canaccord Genuity reiterated a “hold” rating and set a $50.00 target price (up previously from $45.00) on shares of Xylem in a research report on Tuesday, August 16th. RBC Capital Markets set a $51.00 target price on Xylem and gave the stock a “buy” rating in a research report on Tuesday, August 16th. Royal Bank Of Canada boosted their target price on Xylem from $47.00 to $51.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 16th. Finally, Barclays PLC boosted their target price on Xylem from $39.00 to $45.00 and gave the stock an “equal weight” rating in a research report on Monday, July 18th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Xylem presently has an average rating of “Hold” and an average price target of $45.00.

In other news, Director Steven R. Loranger sold 33,887 shares of Xylem stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $48.11, for a total transaction of $1,630,303.57. Following the sale, the director now owns 11,243 shares of the company’s stock, valued at $540,900.73. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Tomas Brannemo sold 8,524 shares of Xylem stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $50.06, for a total value of $426,711.44. The disclosure for this sale can be found here. Insiders own 0.77% of the company’s stock.

Xylem Company Profile

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.